The Toll–Like Receptor 2/6 Agonist, FSL–1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome

Risks of radiation exposure from nuclear incidents and cancer radiotherapy are undeniable realities. These dangers urgently compel the development of agents for ameliorating radiation–induced injuries. Biologic pathways mediated by myeloid differentiation primary response gene 88 (MyD88), the common...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurkjian, Cathryn J., Guo, Hao, Montgomery, Nathan D., Cheng, Ning, Yuan, Hong, Merrill, Joseph R., Sempowski, Gregory D., Brickey, W. June, Ting, Jenny P.-Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725477/
https://www.ncbi.nlm.nih.gov/pubmed/29230065
http://dx.doi.org/10.1038/s41598-017-17729-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725477/
https://www.ncbi.nlm.nih.gov/pubmed/29230065
http://dx.doi.org/10.1038/s41598-017-17729-9

Ejemplares similares